CD8A and neoplasm: The colorectal Immunoscore, which involved a quantitative assessment of CD3+ and CD8+ T cells both at the invasive margin and bulk of the tumor, was already published in 2006 and encouraged the adoption of digital pathology tools for biomarker discovery (70, 71).